{"topic_id":"ade_sulfaquinoxaline_adverse_events","category":"ade","context":"---\ntopic_id: ade_sulfaquinoxaline_adverse_events\ncategory: ade\ntitle: \"FDA ADE reports for Sulfaquinoxaline (active ingredient) — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b32.json\ndate_parsed: 2026-07-22\ntokens_estimated: 328\nverification:\n  method: substring_match\n  claims: 26\n  passed: 26\n  date: 2026-07-22\n---\n\n# Sulfaquinoxaline — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Sulfaquinoxaline is a active ingredient.\n\n## Total reports\nSulfaquinoxaline: 4\n\n## Reports by species (top entries)\n- Chicken 2\n- Turkey 2\n\n## Top reported reactions (VEDDRA terms, top entries)\n- Death 2\n- Lack of efficacy (bacteria) - NOS 2\n- DEATH-TREATMENT FAILURE 1\n- Depression 1\n- PR-BONE MARROW, LESION(S) 1\n- PR-KIDNEY(S), LESION(S) 1\n- PR-MULTIPLE SITES, BLOOD 1\n- Pallor 1\n- Respiratory distress 1\n- Swelling NOS 1\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b32.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":231,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}